3 ASX All Ords shares up 50%+ in March

The Australian share market is on course to record a solid gain in March.

As things stand, the ASX All Ordinaries index is up 2.3% month to date.

While that is very positive, it pales in comparison to some of the gains that have been recorded on the index.

For example, the three ASX All Ords shares listed below are up over 50% this month. Let’s see why investors have been fighting to get hold of these shares:

Life360 Inc (ASX: 360)

The Life360 share price is up 61% month to date. The key driver of this gain has been the release of the location technology company’s FY 2023 results at the beginning of March. Life360 reported subscription revenue of US$200 million, which was up 52% year on year and ahead of guidance. Also coming in comfortably ahead of guidance was its adjusted EBITDA of US$20.6 million. This compares to its guidance range of US$12 million to US$16 million. The announcement of a new advertising business also got the market excited.

Mesoblast Ltd (ASX: MSB)

The Mesoblast share price is up 67% since the end of last month. This has been driven almost entirely by the release of an announcement this week from the ASX All Ords share relating to the US Food and Drug Administration (FDA). The FDA advised that there appears to be sufficient results to support the submission of the biotechnology company’s proposed Biologics License Application (BLA) for remestemcel-L to treat paediatric patients with steroid-refractory acute graft versus host disease.

Zip Co Ltd (ASX: ZIP)

The Zip share price is up 58% in March. Investors have been scrambling to buy this ASX All Ords share thanks to its strong performance so far in FY 2024 and a couple of bullish broker notes. In respect to the latter, the previously ultra-bearish team at UBS has changed its tune on the buy now pay later provider. This saw the broker upgrade Zip’s shares from a neutral rating with a 36 cents price target to a buy rating with a $1.43 price target. The team at Citi also made a similar move, upgrading the company’s shares to a buy rating and $1.40 price target (from neutral and 78 cents).

The post 3 ASX All Ords shares up 50%+ in March appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher
• Mesoblast share price rockets 36% on breaking FDA news
• Why are these ASX tech shares getting smashed today?
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in Life360. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Zip Co. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/B0G2vwh